Diabetic Retinopathy in China 2026: cost by stage
There is no single price for diabetic retinopathy, because it isn't a single procedure — it's a spectrum that runs from a $120 monitoring visit to $3,000–5,000 vitrectomy surgery, and the stage you're at decides both the treatment and whether flying anywhere is sensible at all. This guide prices each stage in China as researched in July 2026, then answers the question the cost pages skip: diabetic eye disease is chronic and schedule-driven, so which stages actually suit medical travel — and which ones you should treat at home.
Screening/staging visit with OCT $120–300 · PRP laser $250–550 per session (2–3 sessions per eye) · anti-VEGF injection $300–800 · five-injection DME loading course $1,500–3,500 per eye · steroid implant $700–1,400 · diabetic vitrectomy $3,000–5,000 per eye. Good reasons to travel: a complete PRP course, vitrectomy, a steroid implant, a real second opinion on staging. Bad reason to travel: the maintenance phase of macular edema — nobody should fly to China monthly for injections.
Stage first: where you are decides everything
Diabetic retinopathy is staged on what the retina shows, and separately on whether the macula — the small central area you read with — is swollen. Those two axes, not the price list, determine your options:
| Stage | Usual management | Does travel make sense? |
|---|---|---|
| Mild / moderate non-proliferative (NPDR), no macular edema | Monitoring at defined intervals plus glucose, blood-pressure and lipid control — no eye procedure | No. Get screened locally. A trip buys you nothing a home clinic can't do |
| Severe NPDR, no macular edema | Close surveillance; PRP laser considered pre-emptively in selected cases | Maybe — worth a specialist opinion; treatment decision is genuinely debatable at this stage |
| Diabetic macular edema (DME), centre-involving | Anti-VEGF injection course, sometimes macular laser or a steroid implant | Loading phase yes, maintenance no — see the schedule problem below |
| Proliferative (PDR) — new vessels growing | PRP laser course, often with anti-VEGF; urgent if new vessels are active | Yes — a defined course that completes in one trip |
| Advanced PDR: vitreous haemorrhage, tractional retinal detachment | Vitrectomy, frequently combined with laser, membrane dissection and sometimes cataract surgery | Yes if stable and planned — no if symptoms are new or worsening |
If nobody has actually staged your eyes with a dilated examination and an OCT scan, that's the first thing to buy — anywhere. A quote for treatment written before staging is not a medical plan.
What each stage costs (researched July 2026)
| Item | China (standard range) | US private-pay | Notes |
|---|---|---|---|
| Dilated exam + OCT + fundus photography | $120–300 | $400–900 | The staging visit; also the annual monitoring visit |
| Fluorescein angiography (FFA) or OCT-angiography | $80–220 | $300–700 | Maps leakage and ischaemia when treatment is being planned |
| Panretinal photocoagulation (PRP), per session | $250–550 | $1,000–2,000 | 2–3 sessions per eye is typical |
| PRP full course, per eye | $600–1,400 | $2,500–5,000 | Completes within one 10–14 day trip |
| Focal / grid macular laser, per eye | $200–450 | $800–1,600 | Selected non-centre-involving edema |
| Anti-VEGF injection, per injection | $300–800 | $1,800–2,400 | Drug choice drives the range (see below) |
| DME loading course (5 injections), per eye | $1,500–3,500 | $9,000–14,000 | Roughly monthly — the phase that constrains travel |
| Intravitreal steroid implant, per eye | $700–1,400 | $1,800–3,000 | Longer-acting option; raises pressure/cataract risk |
| Diabetic vitrectomy, per eye | $3,000–5,000 | $10,000–15,000 | Above the general vitrectomy range — see why below |
| Combined vitrectomy + cataract surgery | +$800–1,500 | +$3,000–5,000 | Common in diabetic eyes; one anaesthetic, one recovery |
Ranges are standard partner-hospital fee schedules researched July 2026, against published US private-pay references; Western-European private rates typically sit 20–35% below the US figures. Diabetic vitrectomy sits above the general vitrectomy range on our glaucoma & retina cost guide ($2,500–4,500) for a real clinical reason: diabetic cases often involve dissecting fibrovascular membranes off a fragile retina, endolaser during surgery, and sometimes a tamponade — longer operating time and more consumables than a straightforward macular-hole or membrane case. Anyone quoting diabetic vitrectomy at the bottom of a generic vitrectomy range hasn't seen your imaging. For every other procedure, see the full China eye surgery price guide.
Diabetic macular edema is treated on a cadence, not in a single event: typically a loading phase of injections roughly every four weeks, then continued treatment at intervals set by how the macula responds, potentially for years. No sensible plan involves flying to China every month. So be blunt about what a trip can and can't be:
- Suits travel — a complete PRP laser course; planned diabetic vitrectomy; a steroid implant; a staging second opinion when you've been told nothing can be done; the start of an injection course with an explicit handover.
- Doesn't suit travel — indefinite monthly injection maintenance; mild NPDR that only needs monitoring; anything acute and changing.
- The condition of a responsible plan — you have a home retina specialist who has already agreed to continue the schedule, before you book a flight. If that person doesn't exist yet, arranging them is step one, not step five.
We would rather tell you your stage is better managed at home than book a trip that interrupts a schedule your sight depends on.
Why injections cost less here: the domestic drug tier
The anti-VEGF range above is wide because the drug drives it. China has a domestic tier that most Western systems lack: conbercept, developed by a Chinese manufacturer and approved in China for diabetic macular edema in 2019 and subsequently covered by national medical insurance, along with domestic ranibizumab biosimilars. Imported aflibercept and originator ranibizumab sit at the top of the Chinese range and are what you'd be quoted in the US or Europe. Published cost-effectiveness work in China has compared these agents directly and found the domestic option competitive — which is a health-economics finding, not a promise about your eye.
Three questions worth asking at consultation, in writing:
- Which drug, specifically? Name and manufacturer, not "anti-VEGF".
- What dosing interval is planned, and does that change with the drug chosen? Interval matters more than unit price if you're travelling.
- Is the same drug available at home? If a domestic Chinese agent is used for loading and your home specialist can only continue with a different one, that switch should be a planned decision documented in your notes — not a surprise your next doctor discovers.
Drug choice is a clinical decision that belongs to the treating retina specialist, weighing your macular anatomy, previous response and how often you can realistically attend. Cheapest vial is not a treatment plan.
Diabetes co-management: the part that isn't ophthalmology
Diabetic eye surgery is safer when the rest of the diabetes is accounted for, and the good Chinese academic centres are set up for this — their ophthalmology departments sit inside large general hospitals with endocrinology and nephrology on the same campus. Practical implications for a trip:
- Bring recent numbers — HbA1c, blood pressure readings, kidney function (eGFR, creatinine, urine protein) and your full medication list including insulin doses, oral agents and any GLP-1 agonist.
- Plan the operating day — fasting for anaesthesia interacts with insulin and oral hypoglycaemics. Ask specifically how your regimen is adjusted, who supervises glucose on the day, and what happens if you run high or low.
- Renal function matters — fluorescein angiography and any general anaesthetic are planned differently in diabetic kidney disease. Don't leave this to be discovered at admission.
- Vision affects insulin safety — if central vision is poor, dose-drawing and glucose monitoring get harder. Worth naming as a goal of treatment rather than an afterthought.
- One genuine subtlety — very rapid tightening of long-standing poor glucose control can transiently worsen retinopathy. This is a known phenomenon that argues for eye monitoring alongside improving control, coordinated between your ophthalmologist and diabetes doctor. It is not an argument against control.
Our for-foreigners guide covers how international departments handle multi-department coordination, English records and payment, and the hospitals guide explains which institutions have the vitreoretinal depth and the general-hospital backing that diabetic cases want. In city terms, Shanghai offers the most retina redundancy across institutions, Beijing is strongest where systemic disease needs to sit beside the eye work, and Guangzhou concentrates subspecialty depth on one campus; the city comparison weighs those trade-offs against flights.
What a trip looks like, by pathway
| Pathway | Time in China | Shape of the visit |
|---|---|---|
| Staging / second opinion only | 2–3 days | Dilated exam, OCT, angiography if indicated, written staging and options |
| PRP laser course, one or both eyes | 10–14 days | Work-up, 2–3 laser sessions per eye spaced days apart, review before flying |
| DME injection loading start + handover | 4–6 days | Imaging, first injection(s), written schedule and drug details for your home specialist |
| Diabetic vitrectomy | 2–3 weeks | Work-up and medical clearance, surgery, positioning period, multiple retinal reviews; longer if gas tamponade is used |
Vitrectomy patients sometimes receive an intraocular gas bubble, and flying is prohibited until that gas has fully absorbed — weeks, not days, and an absolute rule rather than a preference. Our flying-after-eye-surgery guide explains the physics and the per-procedure windows, including the silicone-oil exception. Build the return ticket around that, and expect the surgeon's clearance to be the deciding voice.
A sudden drop in vision · a shower of new floaters · a red or black haze (possible vitreous haemorrhage) · a curtain or shadow across the field · new pain with redness. Diabetic eye disease can threaten sight faster than any itinerary can be arranged. Get assessed locally within days, get imaging, and only then decide whether planned surgery abroad is the right next step. We say no to trips for this reason regularly, and it is the right answer.
The handover: what you take home
For a chronic disease this is the deliverable that decides whether the trip helped or just interrupted your care. Insist on all of it, in English, before you leave:
- Staging diagnosis for each eye in standard terminology, with macular status stated separately.
- Baseline and post-treatment OCT scans as images, not merely a summary — your home specialist needs to compare, and central retinal thickness numbers alone aren't enough.
- Fundus photographs and any angiography, plus the laser record: parameters and number of PRP spots per eye, so a future clinician knows how much retina has already been treated.
- Injection log — exact drug name, dose, eye and date for each injection given.
- Operative note for any surgery, including tamponade used and positioning instructions.
- The next due date — when the next injection or review should happen. This is the item most often missing, and the one that matters most.
If your case turns out to be glaucoma or another retinal condition rather than diabetic disease, our glaucoma & retina cost guide covers those pathways, and our safety assessment addresses the standards question directly.
Frequently asked questions
How much does diabetic retinopathy treatment cost in China?
By stage: staging visit with OCT $120–300; PRP laser $250–550 per session and $600–1,400 for a full per-eye course; anti-VEGF $300–800 per injection ($1,500–3,500 for a five-injection loading course per eye); steroid implant $700–1,400; diabetic vitrectomy $3,000–5,000 per eye (standard ranges, researched July 2026). Confirmed in writing per case after imaging.
Is it worth flying to China for diabetic eye disease?
For a complete PRP course, planned vitrectomy, a steroid implant or a genuine staging second opinion — yes. For indefinite monthly injection maintenance or mild disease that only needs monitoring — no. The workable pattern is a defined block of treatment plus a documented handover to a home retina specialist arranged before you travel.
Why are anti-VEGF injections cheaper here?
China has a domestic drug tier — conbercept (approved there for diabetic macular edema in 2019) and domestic ranibizumab biosimilars — that most Western systems lack; imported aflibercept and originator ranibizumab sit at the top of the range. Ask which drug specifically, what interval is planned, and whether your home specialist can continue with it.
What diabetes control do I need before surgery?
Bring recent HbA1c, blood pressure and kidney-function results plus your full medication list, and agree a fasting-day insulin plan with the team. Uncontrolled hypertension, poor renal function and unstable glucose all raise risk. Rapid tightening of long-standing poor control can transiently worsen retinopathy, which is a reason to coordinate eye and diabetes care — not to avoid control.
Can a PRP course be finished in one trip?
Usually yes — PRP is normally split into 2–3 sessions per eye spaced days to a couple of weeks apart, so 10–14 days can complete one or both eyes with a review before flying. Expect a peripheral- and night-vision trade-off, which protects central sight and should be explained before consent.
I have sudden vision loss or new floaters — should I book?
No. Be seen locally within days. Sudden vision loss, a shower of floaters, a red or black haze or a curtain across your vision need assessment on a timescale no travel plan can match. Get imaging first, then decide about planned surgery abroad.
What records should I take home?
Staging per eye, OCT scans as images, fundus photos and angiography, the laser record (parameters and spot counts), an injection log with drug names and dates, the operative note, and the date the next injection or review is due — the item most often missing.